Related Experiment Video
Updated: Mar 18, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Strategic DAPT Interruption for Enlarging LV Pseudoaneurysm After Myocardial Infarction in a Dialysis Patient
Takeyoshi Kameyama1, Yuki Kurose1, Minoru Yambe1
1Faculty of Medicine, Division of Cardiovascular Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Background:
Left ventricular pseudoaneurysm following acute myocardial infarction carries a high risk of rupture and typically requires surgical repair.
Case Summary:
A man in his 40s on maintenance hemodialysis presented with lateral-wall ST-segment elevation myocardial infarction during dialysis. Primary percutaneous coronary intervention successfully recanalized the occluded left circumflex artery. On day 26, echocardiography revealed a 15-mm left ventricular pseudoaneurysm that enlarged to 19 mm by day 38 (≈30% increase). Given prohibitive surgical risk due to multiple comorbidities and multidisciplinary heart team assessment, conservative management with strategic complete interruption of dual antiplatelet therapy was undertaken on day 39. Complete thrombosis occurred by day 53 without complications. Aspirin monotherapy was resumed on day 56. The 21-month follow-up demonstrated complete absorption.
Discussion:
Progressive enlargement rendered continued conservative observation insufficient. Following careful multidisciplinary evaluation in a surgically prohibitive, high-risk patient, strategic interruption of dual antiplatelet therapy was associated with complete thrombosis.
Take-Home Messages:
Small left ventricular pseudoaneurysms in high-risk patients may be managed conservatively with intensive surveillance. Rapid enlargement may signal impending rupture and, in selected cases with multidisciplinary consensus, warrant consideration of strategic dual antiplatelet therapy interruption.
More Related Videos
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure VI: Adjunct Therapies
Hemodialysis II: Procedure and Complications

